Skip to main content
. Author manuscript; available in PMC: 2021 Jul 27.
Published in final edited form as: Curr Breast Cancer Rep. 2020 Nov 24;13(1):1–18. doi: 10.1007/s12609-020-00397-6

Table 9.

Associations between biomarkers and lymphedema symptom classes at 8 weeks post-surgery

Biomarkers pg/mL Low symptom class Moderate symptom class Severe symptom class p value
Mean Ln(IL1-α) levels
 Pre-surgery 0.95 (1.76) − 0.25 (1.62) − 1.92 (1.69) 0.0012; A>C
 8 weeks post-surgery 0.20 (1.45) − 0.46 (1.35) − 1.90 (1.63) 0.0079; A>C
 12 months post-surgery − 1.01 (1.86) − 0.97 (0.90) − 1.94 (0.79) 0.5432
Mean Ln(IL-4) levels
 Pre-surgery − 3.48 (0.92) − 3.33 (1.01) − 2.83 (1.31) 0.0525
 8 weeks post-surgery − 3.46 (1.01) − 3.42(1.08) − 2.85 (1.21) 0.0747
 12 months post-surgery − 3.31 (1.41) − 3.63 (0.96) − 2.99 (1.54) 0.2226
Mean Ln(IL-6) levels
 Pre-surgery 0.12* (1.32) 0.28* (1.52) 1.15 (1.79) 0.0168; A<C
 4–8 weeks post-surgery 0.38* (1.34) 0.66* (1.51) 1.17 (1.67) 0.0835
 12 months post-surgery 0.30* (1.46) 0.45* (1.68) 0.78 (1.94) 0.4838
Mean Ln(IL-8) levels
 Pre-surgery 2.39 (0.99) 2.11 (1.08) 1.63 (1.78) 0.0334; A>C
 4–8 weeks post-surgery 2.36(1.15) 2.04 (1.18) 1.98 (1.79) 0.3358
 12 months post-surgery 2.45 (1.04) 2.18 (1.23) 2.09 (1.19) 0.3171
Mean Ln(IL-10) levels
 Pre-surgery − 1.38 (0.66) −1.49 (0.61) − 1.61 (1.39) 0.5250
 4–8 weeks post-surgery − 1.40 (0.80) −1.56 (0.84) − 1.60 (1.39) 0.5966
 12 months post-surgery − 1.25 (0.94) −1.50 (0.51) − 1.01 (1.06) 0.1060
Mean Ln(IL-13) levels
 Pre-surgery − 1.07 (1.19) −1.05 (1.16) − 1.75 (1.33) 0.2814
 4–8 weeks post-surgery 1.46 (1.34) −1.95 (2.11) − 2.21 (1.88) 0.4162
 12 months post-surgery − 1.04 (1.58) − 0.67 (1.79) − 1.41 (1.72) 0.4407
Mean Ln(VEGF) levels
 Pre-surgery 4.54** (0.62) 4.75* (0.78) 4.90*** (0.71) 0.0681
 8 weeks post-surgery 4.50** (0.65) 4.73* (0.78) 4.96*** (0.80) 0.0290; A< C
 12 months post-surgery 4.27** (0.83) 4.56* (0.78) 4.59*** (0.81) 0.1130
Mean Ln(VEGFC) levels
 Pre-surgery 6.09** (0.44) 6.03* (0.56) 6.12 (0.47) 0.6978
 4–8 weeks post-surgery 5.88** (0.50) 5.89* (0.67) 6.04 (0.49) 0.4847
 12 months post-surgery 5.93** (0.52) 5.97* (0.37) 5.92 (0.53) 0.8746
Mean Ln(VEGFD) levels
 Pre-surgery 7.34*** (0.62) 7.26*** (0.54) 7.30* (0.48) 0.7835
 4–8 weeks post-surgery 6.88*** (0.44) 6.76*** (0.40) 6.98* (0.51) 0.1380
 12 months post-surgery 7.03*** (0.63) 6.95*** (0.54) 7.18* (0.53) 0.3228
Mean Ln(TNF-α) levels
 Pre-surgery 0.65*** (0.40) 0.55*** (0.40) 0.49 (1.20) 0.5697
 4–8 weeks post-surgery 0.81*** (0.56) 0.85*** (0.35) 0.73 (0.96) 0.7381
 12 months post-surgery 0.79*** (0.44) 0.75*** (0.38) 0.67 (0.43) 0.5138

A (low), B (moderate), and C (severe) symptom class pairwise differences between the three classes with a Bonferroni correction at the 5% alpha level

*

p < 0.05

**

p <0.01

***

p < 0.001 – repeated measures ANOVA over the three time points show changes over time